Stem Cells Europe Agenda

Registration

Signals, Stochastic and Epigenetic Factors Regulating Pluripotency and Cell Fate in Embryos and Stem Cells
Claudio Stern, Professor, University College London, United Kingdom

This talk will discuss timing and cell heterogeneity in relation to pluripotency and the acquisition of neural fate in embryos in vivo and embryonic and gonocyte-derived stem cells in vitro.

Induction of Pluripotent Stem Cells
Holm Zaehres, Professor, Max Planck Institute, Germany

This presentation will describe the current status of strategies to generate induced pluripotent stem (iPS) cells from mouse and human somatic cells for patient-specific disease modeling and cell therapeutic applications.

Coffee and Networking in Exhibition Hall

Clinical Grade Pluripotent Stem Cells - Where are We Now
Dusko Ilic, Senior Lecturer/Reader, Kings College London, United Kingdom

Generation of Chondrogenic Cells from Human Embryonic Stem Cells
Sue Kimber, Professor of Stem Cells & Reproductive Biology, University of Manchester, United Kingdom

This talk will focus on the development of defined system for generation of chondrogenic cells from human ES cells with potential for cellular therapy.

A Defined System for Human Pluripotent Stem Cell Culture and Differentiation
Poh Tan, Product Manager, Stemcell Technologies Inc, Canada

This talk will describe the use of a completely defined feeder-free based system for the culture and maintenance and differentiation of hPSCs.

Technology Spotlight:
Meeting cGMP Requirements and Process Challenges for the Development of Viral-based Therapeutics
Tim Calvert, Account Manager, Lonza Biosciences

Lunch and Networking in Exhibition Hall

Poster Viewing Session

Stem Cells and the IP Landscape - Changing or Status Quo
Philippa Montgomerie, Partner, DLA Piper, United Kingdom

Coffee and Networking in Exhibition Hall

Stem Cell Legislation Across the EU - Trends, Pitfalls and Opportunities for Academic Research and Industry
Timo Faltus, Research Associate, Martin-Luther-University, Germany

This presentation provides an overview of European stem cell regulations. The talk includes a comparison of the regulations in different EU countries and focuses on the current trends especially in German stem cell law.

Market Trends in Stem Cell Research and Cellular Therapy: Qualitative and Quantitative Analysis
Enal Razvi, Managing Director, Select Biosciences Inc, United States of America

This talk presents a snapshot from the most-recent market analysis performed by Select Biosciences that characterizes the technology and commercial trends in stem cell research and cellular therapy. Quantitative market metrics frame the field in terms of segments, penetrance of various technologies/products/vendors, as well as the emerging themes in the deployment of different stem cell types for cellular therapy.

Panel Discussion - Scottish Stem Cell Network
Michael Leek, Business Development Director, Immunosolv, United Kingdom

Panel Discussion - Scottish Stem Cell Network
Michael Leek, Business Development Director, Immunosolv, United Kingdom

Drinks Reception

International Coordination of Stem Cell Banks
Glyn Stacey, Director, UK Stem Cell Bank, United Kingdom

The study of human stem cell biology and delivery of cells for human therapy require careful standardisation and quality control. This lecture will look at the mechanisms by which these important support elements are delivered through an international network of stem cell banks delivering human stem cell lines for research and development.

The NHS Cord Blood Bank: 15 Years On
Andrew Hadley, General Manager, NHS Blood and Transplant, United Kingdom

Stem cell transplantation using umbilical cord blood is firmly established as a curative treatment for patients with leukaemia. The UK's strategy for collecting and banking cord blood will be described and new approaches to expanding cord blood stem cells and improving post-transplant outcomes will be reviewed.

Coffee and Networking in Exhibition Hall

New Blood: Using Stem Cells to Generate Erythrocytes for Transfusion
Jo Mountford, Lecturer, University of Glasgow, United Kingdom

Use of Nanostructured Materials to Influence Mesenchymal Stem Cell Behaviour
Matt Dalby, Reader, University of Glasgow, United Kingdom

The presentation will focus on nanoscale topographical features and the range of influence they can infer and the possible echantransductive mechanisms the cells may use.

Chemical Driving of Smad Gene Expression and Signaling Orchestrates Cardiogenesis in Mouse Embryonic and Human Mesenchymal Stem Cells
Carlo Ventura, Professor, University of Bologna, Italy

The use of hyaluronan esters paves novel combinatorial strategies of molecular and stem cell cardiovascular therapy based on fine tuning of targeted Smad transcription and signaling.

Lunch and Networking in Exhibition Hall

Poster Viewing Session

Functional Improvement of Silica Fibrosis Murine Model by Human Embryonic Stem Cells
Federica Sangiuolo, Assistant Professor, University of Rome Tor Vergata, Italy

This presentation will demonste the capacity of hES cells to differentiate into type II pneumocytes in vitro and to repair in vivo lung damage in silica fibrosis disease models. hES can be considered a promising way to cure lung fibrosis by a cell therapy approach.

An Endogenous Small RNA Specifies the Hematopoiesis of Mesenchymal Stem Cells by Repressing EID1
James Yin, Professor, Institute of Stem Cells, China

Coffee and Networking in Exhibition Hall

Designing and Running a Phase I Trial of Neural Stem Cells in Stroke: PISCES (Preliminary Investigation of Stem Cells in Stroke) Experience
Keith Muir, Professor, University of Glasgow, United Kingdom

Heterogeneity of Tumour Cells Seeded into Blood as Analyzed by Multiplex PCR of Individual Cells Singled out by Micro-capillary Manipulation
Katharina Pachmann, Senior Scientist, Universitätsklinikum Jena, Germany

Close of Conference